These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss. Day EA; Ford RJ; Smith BK; Mohammadi-Shemirani P; Morrow MR; Gutgesell RM; Lu R; Raphenya AR; Kabiri M; McArthur AG; McInnes N; Hess S; Paré G; Gerstein HC; Steinberg GR Nat Metab; 2019 Dec; 1(12):1202-1208. PubMed ID: 32694673 [TBL] [Abstract][Full Text] [Related]
4. Managing type 2 diabetes mellitus in patients with obesity. Hauner H Treat Endocrinol; 2004; 3(4):223-32. PubMed ID: 16026105 [TBL] [Abstract][Full Text] [Related]
5. Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes. Lee A; Morley JE Obes Res; 1998 Jan; 6(1):47-53. PubMed ID: 9526970 [TBL] [Abstract][Full Text] [Related]
6. Metformin-associated prevention of weight gain in insulin-treated type 2 diabetic patients cannot be explained by decreased energy intake: A post hoc analysis of a randomized placebo-controlled 4.3-year trial. Out M; Miedema I; Jager-Wittenaar H; van der Schans C; Krijnen W; Lehert P; Stehouwer C; Kooy A Diabetes Obes Metab; 2018 Jan; 20(1):219-223. PubMed ID: 28681986 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of Metformin Treatment with Respect to Weight Reduction in Children and Adults with Obesity: A Systematic Review. Lentferink YE; Knibbe CAJ; van der Vorst MMJ Drugs; 2018 Dec; 78(18):1887-1901. PubMed ID: 30511324 [TBL] [Abstract][Full Text] [Related]
8. [Pharmacological therapy of obesity]. Pagotto U; Vanuzzo D; Vicennati V; Pasquali R G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755 [TBL] [Abstract][Full Text] [Related]
9. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. ; Knowler WC; Fowler SE; Hamman RF; Christophi CA; Hoffman HJ; Brenneman AT; Brown-Friday JO; Goldberg R; Venditti E; Nathan DM Lancet; 2009 Nov; 374(9702):1677-86. PubMed ID: 19878986 [TBL] [Abstract][Full Text] [Related]
10. Amylin improves the effect of leptin on insulin sensitivity in leptin-resistant diet-induced obese mice. Kusakabe T; Ebihara K; Sakai T; Miyamoto L; Aotani D; Yamamoto Y; Yamamoto-Kataoka S; Aizawa-Abe M; Fujikura J; Hosoda K; Nakao K Am J Physiol Endocrinol Metab; 2012 Apr; 302(8):E924-31. PubMed ID: 22275759 [TBL] [Abstract][Full Text] [Related]
11. Metformin: Mechanisms in Human Obesity and Weight Loss. Yerevanian A; Soukas AA Curr Obes Rep; 2019 Jun; 8(2):156-164. PubMed ID: 30874963 [TBL] [Abstract][Full Text] [Related]
13. Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action. Grams J; Garvey WT Curr Obes Rep; 2015 Jun; 4(2):287-302. PubMed ID: 26627223 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological and non-pharmacological strategies for obese women with subfertility. Taghavi SA; van Wely M; Jahanfar S; Bazarganipour F Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012650. PubMed ID: 33765343 [TBL] [Abstract][Full Text] [Related]
15. Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial. Bohula EA; Scirica BM; Inzucchi SE; McGuire DK; Keech AC; Smith SR; Kanevsky E; Murphy SA; Leiter LA; Dwyer JP; Corbalan R; Hamm C; Kaplan L; Nicolau JC; Ophuis TO; Ray KK; Ruda M; Spinar J; Patel T; Miao W; Perdomo C; Francis B; Dhadda S; Bonaca MP; Ruff CT; Sabatine MS; Wiviott SD; Lancet; 2018 Nov; 392(10161):2269-2279. PubMed ID: 30293771 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the safety and efficacy of sibutramine, orlistat and metformin in the treatment of obesity. Gokcel A; Gumurdulu Y; Karakose H; Melek Ertorer E; Tanaci N; BascilTutuncu N; Guvener N Diabetes Obes Metab; 2002 Jan; 4(1):49-55. PubMed ID: 11874442 [TBL] [Abstract][Full Text] [Related]
17. Effects of metformin on energy intake and satiety in obese children. Adeyemo MA; McDuffie JR; Kozlosky M; Krakoff J; Calis KA; Brady SM; Yanovski JA Diabetes Obes Metab; 2015 Apr; 17(4):363-70. PubMed ID: 25483291 [TBL] [Abstract][Full Text] [Related]
18. Obesity medications and the treatment of type 2 diabetes. Greenway F Diabetes Technol Ther; 1999; 1(3):277-87. PubMed ID: 11475274 [TBL] [Abstract][Full Text] [Related]
19. Synergistic Effects of a GPR119 Agonist with Metformin on Weight Loss in Diet-Induced Obese Mice. Al-Barazanji K; McNulty J; Binz J; Generaux C; Benson W; Young A; Chen L J Pharmacol Exp Ther; 2015 Jun; 353(3):496-504. PubMed ID: 25770135 [TBL] [Abstract][Full Text] [Related]
20. The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program. Franks PW; Jablonski KA; Delahanty L; Hanson RL; Kahn SE; Altshuler D; Knowler WC; Florez JC; Diabetologia; 2007 Dec; 50(12):2451-60. PubMed ID: 17898990 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]